Canada markets closed

MIRA Pharmaceuticals, Inc. (MIRA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.7380+0.0279 (+3.93%)
At close: 04:00PM EDT
0.7400 +0.00 (+0.27%)
After hours: 07:37PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.91M
Enterprise Value 7.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.46
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-88.50%
S&P500 52-Week Change 323.76%
52 Week High 36.9500
52 Week Low 30.6310
50-Day Moving Average 30.8248
200-Day Moving Average 31.9103

Share Statistics

Avg Vol (3 month) 3131.2k
Avg Vol (10 day) 336.67k
Shares Outstanding 514.78M
Implied Shares Outstanding 614.78M
Float 89.07M
% Held by Insiders 129.11%
% Held by Institutions 14.26%
Shares Short (May 15, 2024) 414.66k
Short Ratio (May 15, 2024) 40.32
Short % of Float (May 15, 2024) 40.16%
Short % of Shares Outstanding (May 15, 2024) 40.10%
Shares Short (prior month Apr 15, 2024) 442.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-266.11%
Return on Equity (ttm)-1,807.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-12.36M
Diluted EPS (ttm)-0.6600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.53M
Total Cash Per Share (mrq)0.24
Total Debt (mrq)1.27k
Total Debt/Equity (mrq)0.04%
Current Ratio (mrq)5.70
Book Value Per Share (mrq)0.21

Cash Flow Statement

Operating Cash Flow (ttm)-4.51M
Levered Free Cash Flow (ttm)-4.55M